Silverfin false false 30/04/2024 30/04/2024 01/05/2023 The principal activity of the Company during the financial year was cardiac screening. Dr Guido Pieles 03/04/2017 10704557 2024-04-30 10704557 bus:Director1 2024-04-30 10704557 2023-04-30 10704557 core:CurrentFinancialInstruments 2024-04-30 10704557 core:CurrentFinancialInstruments 2023-04-30 10704557 2023-05-01 2024-04-30 10704557 bus:Micro-entities 2023-05-01 2024-04-30 10704557 bus:FilletedAccounts 2023-05-01 2024-04-30 10704557 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 10704557 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 10704557 bus:Director1 2023-05-01 2024-04-30 10704557 2022-05-01 2023-04-30 iso4217:GBP xbrli:pure

Company No: 10704557 (England and Wales)

CARDIAC HEALTH AND PERFORMANCE LIMITED

Unaudited Financial Statements
For the financial year ended 30 April 2024
Pages for filing with the registrar

CARDIAC HEALTH AND PERFORMANCE LIMITED

UNAUDITED FINANCIAL STATEMENTS

For the financial year ended 30 April 2024

Contents

CARDIAC HEALTH AND PERFORMANCE LIMITED

BALANCE SHEET

As at 30 April 2024
CARDIAC HEALTH AND PERFORMANCE LIMITED

BALANCE SHEET (continued)

For the financial year ended 30 April 2024
2024 2023
£ £
Fixed assets 7,030 6,877
Current assets 218,106 376,316
Prepayments and accrued income 29,735 15,721
Creditors: amounts falling due within one year ( 221,174) ( 44,080)
Net current assets 26,667 347,957
Total assets less current liabilities 33,697 354,834
Accruals and deferred income ( 6,278) ( 7,822)
Net assets 27,419 347,012
Capital and reserves 27,419 347,012

For the financial year ending 30 April 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Cardiac Health and Performance Limited (registered number: 10704557) were approved and authorised for issue by the director on 23 January 2025 and were signed on its behalf by:

Dr Guido Pieles
Director
CARDIAC HEALTH AND PERFORMANCE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 April 2024
CARDIAC HEALTH AND PERFORMANCE LIMITED

NOTES TO THE FINANCIAL STATEMENTS (continued)

For the For the financial year ended 30 April 2024

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 10704557). The address of its registered office is 5th Floor 25 King Street, Bristol, BS1 4PB, United Kingdom.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the financial year, including the director 2 2

3. Directors’ benefits: advances, credit and guarantees

Advances

The Directors loan account is repayable on demand and interest is charged on overdrawn balances exceeding £10,000 at the official HMRC rates.

At 1 May 2023, the balance owed by the director was £83,183. During the year, £18,163 was advanced to the director, and £261,281 was repaid by the director. At 30 April 2024, the balance owed to the director was £159,935.

At 1 May 2022, the balance owed by the director was £162,661. During the year, £90,263 was advanced to the director, and £169,741 was repaid by the director. At 30 April 2023, the balance owed by the director was £83,183.